Synthesis and Biological Properties of a Novel Cephalosporin FR86521 Having Potent Activity Against Methicillin-resistant Staphylococcus aureus (MRSA)
スポンサーリンク
概要
- 論文の詳細を見る
- 1999-12-25
著者
-
Okuda Shinya
Medicinal Chemistry Research Laboratories
-
MATSUMOTO Satoru
Medicinal Biology Research Laboratories Fujisawa Pharmaceutical Co., Ltd.
-
MATSUMOTO Yoshimi
Medicinal Biollgy Research Laboratories Fujisawa Pharmaceutical Co., Ltd.
-
KAWABATA Kohji
Medicinal Chemistry Research Laboratories, Fujisawa Pharmaceutical Co., Ltd.
-
SAKANE Kazuo
Medicinal Chemistry Research Laboratories, Fujisawa Pharmaceutical Co., Ltd.
-
Sakane Kazuo
Medicinal Chemistry Research Laboratories
-
Sakane Kazuo
Medicinal Chemistry Research Laboratories Fujisawa Pharmaceutical Co. Ltd.
-
KISH Kohei
Medicinal Chemistry Research Laboratories
-
OHKI Hidenori
Medicinal Chemistry Research Laboratories
-
TAWARA Shuichi
Medicinal Biology Research Laboratories
-
Ohki Hidenori
Chemistry Research Laboratories Astellas Pharma Inc.
-
Kawabata Kohji
Medicinal Chemistry Research Laboratories Fujisawa Pharmaceutical Co. Ltd.
-
Tawara S
Pharmacology Research Laboratories Astellas Pharma Inc.
-
Matsumoto S
Pharmacology Research Laboratories Astellas Pharma Inc.
-
Matsumoto Yoshimi
Medicinal Biollgy Research Laboratories Fujisawa Pharmaceutical Co. Ltd.
-
Matsumoto Satoru
Medicinal Biology Research Laboratories Fujisawa Pharmaceutical Co. Ltd.
関連論文
- Direct Comparison of the Pharmacodynamics of Four Antifungal Drugs in a Mouse Model of Disseminated Candidiasis Using Microbiological Assays of Serum Drug Concentrations
- Determination of Antifungal Activities in Serum Samples from Mice Treated with Different Antifungal Drugs Allows Detection of an Active Metabolite of Itraconazole
- In Vivo Antibacterial Activity of FK041, a New Orally Active Cephalosporin
- In Vitro Antibacterial Activity of FK041, a New Orally Active Cephalosporin
- Design, Synthesis and Biological Evaluation of a Novel Series of Potent, Orally Active Adenosine A_1 Receptor Antagonists with High Blood-Brain Barrier Permeability
- New Antitumor Substances, FR901463, FR901464 and FR901465 II. Activities against Experimental Tumors in Mice and Mechanism of Action
- Synthesis and Biological Properties of a Novel Cephalosporin FR86521 Having Potent Activity Against Methicillin-resistant Staphylococcus aureus (MRSA)
- Anti-cachectic Effect of FK317, a Novel Anti-cancer Agent, in Colon26 and LX-1 Models in Mice
- FK317, a Novel Substituted Dihydrobenzoxazine, Exhibits Potent Antitumor Activity against Human Tumor Xenografts in Nude Mice
- Different Effects of FK317 on Multidrug-resistant Tumor in vivo and in vitro
- Cytotoxic Mechanisms of FK317, a New Class of Bioreductive Agent with Potent Antitumor Activity
- A New Aromatase Inhibitor, FR901537 II.Pharmacological and Antitumor Effects
- FR192752, a Novel Orally Active Cephalosporin Synthesis and Biological Properties
- FK463, a Novel Water-soluble Echinocandin Lipopetide: Synthesis and Antifungal Activity
- FK041, a Novel Orally Active Cephalosporin: Synthesis and Biological Properties
- Studies on 3'-Quaternary Ammonium Cephalosporins II Synthesis and Antibacterial Activity of 7β-[(Z)-2-(2-Aminothiazol-4-yl)-2-methoxyiminoacetamido]-cephalosporin Derivatives Bearing Various Ouaternary Ammonium Methyl Groups at the 3 Position
- The Anti-inflammatory Effect of FR188582, a Highly Selective Inhibitor of Cyclooxygenase-2, With an Ulcerogenic Sparing Effect in Rats
- Studies on β-Lactam Antibiotics Synthesis and Antibacterial Activity of Novel C-3 Alkyne-substituted Cephalosporins
- Synthesis and Structure-Activity Relationships of a New Orally Active Caphalosporin, FK482 and the Related Compounds
- SYNTHESIS AND STRUCTURE-ACTIVITY RELATIONSHIPS OF NOVEL CEPHALOSPORINS. CEPHALOSPORINS WITH AMINOHETEROAROMATICS AT THE 7-POSITION
- Use of a serum-based antifungal susceptibility assay to predict the in vivo efficacy of novel echinocandin compounds